We are live on !
Find out more
Athyrium Capital Management Portfolio holdings
AUM
$8.69M
Turnover
0%
1-Year Est. Return
34.58%
This Fund
S&P 500
This Quarter Est. Return
-23.14%
1 Year Est. Return
-34.58%
3 Year Est. Return
-25.1%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.69M
AUM Growth
-$24.9M
(-74%)
Cap. Flow
$0
Cap. Flow % of AUM
Cap. Flow %
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
3.1
years
Top 10 Avg Time Held
3.1
years
Top 20 Avg Time Held
3.1
years
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $5.48M | 63.12% |
1,092,976
| – | – |
2020 Q4
15 quarters
|
|
2
Puma Biotechnology
PBYI
$539M
| $3.2M | 36.88% |
1,256,411
| – | – |
2022 Q1
10 quarters
|
|
Similar funds
JDR
DA
KIM
HSC
HVM
Athyrium Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Athyrium Capital Management held 2 positions worth $8.69M, down 74% from $33.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 0%. Athyrium Capital Management opened no new positions and made no exits, leaving the 2-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 34% a quarter earlier.
- Athyrium Capital Management's ten largest holdings make up 100% of its $8.69M portfolio in Q3 2024.
- Athyrium Capital Management opened 0 new positions and closed 0 in Q3 2024.
- Athyrium Capital Management's portfolio value fell 74% quarter-over-quarter to $8.69M.
Based on Athyrium Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.